| 2.2 |
13.2 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 1.1 |
9.7 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.9 |
5.5 |
GO:0002225 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.7 |
2.0 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.6 |
1.9 |
GO:1903576 |
response to L-arginine(GO:1903576) |
| 0.6 |
2.5 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.6 |
1.8 |
GO:0002582 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.6 |
2.3 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.5 |
1.6 |
GO:0034031 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.5 |
0.5 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.5 |
1.6 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 0.5 |
2.1 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.5 |
1.4 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.5 |
1.4 |
GO:0060128 |
corticotropin hormone secreting cell differentiation(GO:0060128) |
| 0.5 |
1.4 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.5 |
1.4 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.4 |
1.3 |
GO:0045608 |
negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 0.4 |
7.0 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.4 |
1.7 |
GO:2000173 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.4 |
1.3 |
GO:0036304 |
umbilical cord morphogenesis(GO:0036304) umbilical cord development(GO:0061027) |
| 0.4 |
1.3 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.4 |
1.3 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.4 |
1.7 |
GO:0032913 |
B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 0.4 |
2.1 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 0.4 |
0.8 |
GO:0051344 |
negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.4 |
1.2 |
GO:0051596 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.4 |
1.2 |
GO:0046066 |
dGDP metabolic process(GO:0046066) |
| 0.4 |
1.2 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.4 |
1.6 |
GO:2000984 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.4 |
1.6 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.4 |
2.0 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.4 |
1.2 |
GO:0019413 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
| 0.4 |
2.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.4 |
1.2 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.4 |
1.5 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.4 |
1.1 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.4 |
2.5 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.4 |
1.1 |
GO:0009386 |
translational attenuation(GO:0009386) |
| 0.4 |
1.1 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 0.3 |
1.0 |
GO:0044537 |
regulation of circulating fibrinogen levels(GO:0044537) |
| 0.3 |
1.0 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 0.3 |
1.4 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.3 |
1.0 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 |
1.0 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.3 |
1.6 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 0.3 |
1.0 |
GO:2000078 |
positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.3 |
0.6 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.3 |
5.3 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 0.3 |
0.9 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.3 |
0.9 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 |
4.9 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.3 |
0.9 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.3 |
3.1 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.3 |
1.2 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.3 |
1.2 |
GO:0034164 |
negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.3 |
0.9 |
GO:0010482 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.3 |
0.9 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.3 |
0.9 |
GO:0042946 |
glucoside transport(GO:0042946) |
| 0.3 |
1.2 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.3 |
11.2 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.3 |
2.6 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.3 |
1.2 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.3 |
1.2 |
GO:1904379 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.3 |
0.9 |
GO:0042377 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.3 |
0.3 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.3 |
0.9 |
GO:2000412 |
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 0.3 |
3.7 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.3 |
0.8 |
GO:0009720 |
detection of hormone stimulus(GO:0009720) |
| 0.3 |
2.5 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.3 |
2.8 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.3 |
2.8 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.3 |
3.8 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.3 |
2.2 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.3 |
0.3 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.3 |
1.4 |
GO:1901091 |
regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.3 |
1.9 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.3 |
1.1 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.3 |
1.3 |
GO:0001306 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.3 |
1.3 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.3 |
1.0 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.3 |
0.8 |
GO:0050976 |
detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.3 |
2.0 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.3 |
2.5 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.3 |
0.3 |
GO:0097252 |
oligodendrocyte apoptotic process(GO:0097252) |
| 0.3 |
3.3 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.3 |
0.8 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
0.7 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.2 |
1.5 |
GO:0033277 |
abortive mitotic cell cycle(GO:0033277) |
| 0.2 |
1.5 |
GO:2000468 |
negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
| 0.2 |
1.2 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 |
1.0 |
GO:0090096 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 |
3.4 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.2 |
0.7 |
GO:0061163 |
endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 0.2 |
1.0 |
GO:0009137 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 |
2.2 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.2 |
0.5 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.2 |
0.7 |
GO:0048560 |
establishment of anatomical structure orientation(GO:0048560) |
| 0.2 |
1.0 |
GO:0097114 |
NMDA glutamate receptor clustering(GO:0097114) |
| 0.2 |
0.5 |
GO:0048541 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.2 |
0.9 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 0.2 |
0.2 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.2 |
1.2 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 |
0.9 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 0.2 |
1.4 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.2 |
0.7 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
0.7 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.2 |
0.9 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.2 |
1.1 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.2 |
0.2 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.2 |
1.1 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 |
0.9 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.2 |
0.7 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.2 |
0.7 |
GO:0036047 |
protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 0.2 |
0.9 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.2 |
0.7 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.2 |
0.2 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.2 |
0.2 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 0.2 |
0.9 |
GO:1900138 |
negative regulation of phospholipase A2 activity(GO:1900138) |
| 0.2 |
0.7 |
GO:0033499 |
galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.2 |
0.9 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.2 |
0.6 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 0.2 |
0.2 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.2 |
0.6 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.2 |
0.6 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.2 |
0.8 |
GO:0044416 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.2 |
0.2 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.2 |
0.6 |
GO:0010841 |
positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.2 |
1.0 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.2 |
0.4 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 |
0.6 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.2 |
0.4 |
GO:0048867 |
stem cell fate determination(GO:0048867) |
| 0.2 |
0.6 |
GO:0002892 |
type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 0.2 |
0.6 |
GO:2000754 |
regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 0.2 |
0.8 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.2 |
0.8 |
GO:0018106 |
peptidyl-histidine phosphorylation(GO:0018106) |
| 0.2 |
0.4 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.2 |
0.6 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.2 |
0.6 |
GO:0035732 |
nitric oxide storage(GO:0035732) |
| 0.2 |
1.2 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.2 |
1.9 |
GO:0098881 |
exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 |
0.8 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.2 |
0.8 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.2 |
1.1 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.2 |
2.1 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
0.6 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.2 |
2.6 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
0.9 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.2 |
0.6 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.2 |
0.4 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.2 |
0.7 |
GO:1904637 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.2 |
0.2 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.2 |
0.5 |
GO:1902303 |
negative regulation of potassium ion export(GO:1902303) |
| 0.2 |
0.9 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.2 |
0.9 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.2 |
0.7 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.2 |
0.9 |
GO:0034351 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.2 |
1.3 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.2 |
0.7 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.2 |
1.6 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.2 |
0.9 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.2 |
0.9 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.2 |
0.5 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.2 |
1.6 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.2 |
0.2 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.2 |
0.7 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.2 |
1.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 |
0.5 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.2 |
0.9 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.2 |
0.5 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 0.2 |
1.0 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.2 |
0.7 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 |
0.2 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.2 |
0.3 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) |
| 0.2 |
0.5 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 |
0.7 |
GO:1903445 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 |
0.5 |
GO:1903778 |
protein localization to vacuolar membrane(GO:1903778) |
| 0.2 |
0.7 |
GO:0051444 |
negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.2 |
3.1 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.2 |
0.7 |
GO:0030472 |
mitotic spindle organization in nucleus(GO:0030472) |
| 0.2 |
1.1 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.2 |
0.2 |
GO:1904393 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) negative regulation of neuromuscular junction development(GO:1904397) |
| 0.2 |
1.1 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.2 |
0.5 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 |
1.6 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 0.2 |
0.5 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 |
0.5 |
GO:0061026 |
cardiac muscle tissue regeneration(GO:0061026) |
| 0.2 |
1.1 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 |
0.5 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.2 |
0.5 |
GO:1902824 |
positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.2 |
0.8 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.2 |
0.8 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.2 |
1.6 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.2 |
1.1 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.2 |
0.5 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 |
0.3 |
GO:0051040 |
regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.2 |
1.1 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.2 |
1.4 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 0.2 |
0.8 |
GO:0006850 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.2 |
0.2 |
GO:0060197 |
cloacal septation(GO:0060197) |
| 0.2 |
0.3 |
GO:0090182 |
regulation of secretion of lysosomal enzymes(GO:0090182) |
| 0.2 |
1.7 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.2 |
0.8 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.2 |
2.6 |
GO:0002138 |
retinoic acid biosynthetic process(GO:0002138) |
| 0.2 |
0.5 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.7 |
GO:0071733 |
transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.1 |
0.9 |
GO:0010266 |
response to vitamin B1(GO:0010266) |
| 0.1 |
1.3 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.1 |
1.9 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
1.0 |
GO:2000489 |
regulation of hepatic stellate cell activation(GO:2000489) |
| 0.1 |
0.3 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
1.3 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
2.7 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.1 |
1.9 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.6 |
GO:0090290 |
positive regulation of osteoclast proliferation(GO:0090290) |
| 0.1 |
3.9 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
1.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.4 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 |
0.9 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
0.4 |
GO:2001033 |
negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 |
0.7 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
0.7 |
GO:0002357 |
defense response to tumor cell(GO:0002357) |
| 0.1 |
1.2 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.3 |
GO:0019520 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.1 |
0.6 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.1 |
0.7 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.1 |
0.3 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.1 |
2.8 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.4 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
0.8 |
GO:0070829 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.4 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.3 |
GO:0060557 |
positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 0.1 |
0.1 |
GO:0035947 |
regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
| 0.1 |
0.1 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.1 |
0.5 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 |
1.1 |
GO:1905245 |
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) regulation of aspartic-type peptidase activity(GO:1905245) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 |
0.3 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.1 |
0.1 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 |
0.1 |
GO:1902164 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.1 |
0.4 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.1 |
0.5 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
1.7 |
GO:0006787 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 |
0.4 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 |
0.7 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.1 |
0.4 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.1 |
0.9 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
0.1 |
GO:0021842 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 |
0.5 |
GO:0072299 |
negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.1 |
0.4 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.1 |
1.2 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.1 |
0.8 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.1 |
1.0 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
1.7 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.1 |
0.5 |
GO:2000980 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.4 |
GO:0021718 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.1 |
0.5 |
GO:0071110 |
protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 0.1 |
0.9 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 0.1 |
0.6 |
GO:0033685 |
negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.1 |
0.5 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.1 |
0.4 |
GO:0042418 |
epinephrine biosynthetic process(GO:0042418) |
| 0.1 |
0.5 |
GO:0098957 |
anterograde axonal transport of mitochondrion(GO:0098957) |
| 0.1 |
2.2 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.1 |
0.4 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
| 0.1 |
0.1 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.1 |
0.4 |
GO:1902232 |
regulation of positive thymic T cell selection(GO:1902232) |
| 0.1 |
0.5 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 |
0.4 |
GO:2000395 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 |
0.1 |
GO:0035992 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.1 |
0.4 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 |
0.8 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.3 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.1 |
1.5 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.1 |
0.5 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.1 |
2.1 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
1.5 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.1 |
1.1 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.1 |
1.5 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.1 |
0.5 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.1 |
2.5 |
GO:0033617 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 0.1 |
0.2 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.1 |
0.7 |
GO:0033029 |
regulation of neutrophil apoptotic process(GO:0033029) |
| 0.1 |
0.4 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.1 |
2.0 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
0.6 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.1 |
0.6 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.1 |
0.4 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.4 |
GO:0001807 |
regulation of type IV hypersensitivity(GO:0001807) |
| 0.1 |
0.1 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
0.6 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.4 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.1 |
0.2 |
GO:0046643 |
regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.1 |
0.8 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
0.4 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.1 |
0.2 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
0.5 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
2.2 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.1 |
1.2 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.4 |
GO:1904597 |
regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.1 |
0.7 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 |
1.4 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.1 |
0.1 |
GO:0036023 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.1 |
0.1 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.1 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.1 |
0.7 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 0.1 |
1.2 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.2 |
GO:0003352 |
regulation of cilium movement(GO:0003352) |
| 0.1 |
0.5 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.1 |
0.8 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.1 |
1.2 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.9 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.1 |
0.6 |
GO:0009608 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.1 |
0.7 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 |
0.2 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
1.9 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
1.3 |
GO:0060295 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 |
0.2 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
2.0 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 |
1.5 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
1.3 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.1 |
0.1 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.1 |
4.6 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.1 |
2.5 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.4 |
GO:0051710 |
regulation of cytolysis in other organism(GO:0051710) |
| 0.1 |
0.4 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.4 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
1.2 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.1 |
0.3 |
GO:0033386 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 |
0.3 |
GO:1904692 |
positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 0.1 |
0.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.1 |
0.5 |
GO:0090034 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 |
0.2 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
0.3 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.1 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 |
0.2 |
GO:0002339 |
B cell selection(GO:0002339) |
| 0.1 |
0.5 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.1 |
0.3 |
GO:0061182 |
negative regulation of chondrocyte development(GO:0061182) |
| 0.1 |
1.4 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.1 |
1.6 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
2.0 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.1 |
GO:0015847 |
putrescine transport(GO:0015847) |
| 0.1 |
0.4 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.1 |
0.1 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.1 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
1.5 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
4.2 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
2.6 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 |
0.6 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 0.1 |
0.1 |
GO:0042091 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.1 |
1.0 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.1 |
0.1 |
GO:0039689 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.1 |
0.8 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.2 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.1 |
0.3 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 |
2.4 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
1.6 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
0.3 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.8 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
2.0 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.1 |
2.0 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.1 |
0.2 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 0.1 |
0.6 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.5 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.1 |
0.5 |
GO:0002741 |
positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 0.1 |
0.6 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.1 |
1.2 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
1.6 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.1 |
0.5 |
GO:0010732 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.1 |
0.1 |
GO:0002730 |
regulation of dendritic cell cytokine production(GO:0002730) |
| 0.1 |
0.1 |
GO:0098909 |
regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.1 |
0.1 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 0.1 |
1.0 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.1 |
0.5 |
GO:0019075 |
virus maturation(GO:0019075) |
| 0.1 |
0.3 |
GO:0090240 |
positive regulation of histone H4 acetylation(GO:0090240) |
| 0.1 |
0.3 |
GO:0090237 |
regulation of arachidonic acid secretion(GO:0090237) |
| 0.1 |
0.2 |
GO:1903301 |
positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.7 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.8 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 |
0.1 |
GO:1903243 |
negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.1 |
0.3 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 |
0.6 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.1 |
0.3 |
GO:0072138 |
mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.1 |
0.3 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.1 |
1.1 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.1 |
0.6 |
GO:1901906 |
diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 |
0.2 |
GO:0072108 |
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
| 0.1 |
0.5 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.2 |
GO:0060809 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.1 |
1.0 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
0.2 |
GO:0071816 |
tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
0.7 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.1 |
0.6 |
GO:0019060 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.8 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
0.7 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.1 |
0.6 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.1 |
0.4 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.1 |
0.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.2 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
0.6 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.5 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.5 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 |
1.3 |
GO:1903441 |
protein localization to ciliary membrane(GO:1903441) |
| 0.1 |
0.1 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.4 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.1 |
0.8 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
0.8 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 |
0.3 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.1 |
0.2 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
| 0.1 |
0.5 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.1 |
GO:0060664 |
epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 0.1 |
1.0 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.1 |
0.3 |
GO:0030920 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.5 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 |
0.5 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 |
1.6 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.4 |
GO:0045872 |
regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
1.4 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.4 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.1 |
0.2 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.3 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
0.3 |
GO:0019640 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.1 |
2.1 |
GO:0098868 |
bone growth(GO:0098868) |
| 0.1 |
1.8 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 |
0.3 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 |
0.7 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
0.5 |
GO:0060669 |
embryonic placenta morphogenesis(GO:0060669) |
| 0.1 |
0.2 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.4 |
GO:0093001 |
glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.1 |
0.9 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.3 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.1 |
0.2 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.1 |
1.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.4 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.2 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.2 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.1 |
0.3 |
GO:1903173 |
phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.1 |
0.7 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.1 |
0.6 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.9 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
0.6 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.9 |
GO:0060546 |
negative regulation of necroptotic process(GO:0060546) negative regulation of necrotic cell death(GO:0060547) |
| 0.1 |
0.9 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.1 |
8.5 |
GO:0070268 |
cornification(GO:0070268) |
| 0.1 |
0.3 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.1 |
0.2 |
GO:0072272 |
proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.1 |
0.1 |
GO:0042635 |
positive regulation of hair cycle(GO:0042635) |
| 0.1 |
0.4 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.1 |
1.8 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.1 |
0.2 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
0.2 |
GO:0002774 |
Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.1 |
0.2 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.1 |
0.3 |
GO:0071681 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 |
0.9 |
GO:0051198 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.1 |
0.5 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.1 |
1.4 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.1 |
0.9 |
GO:1901970 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 |
0.2 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
1.2 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
2.3 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.1 |
0.4 |
GO:0061669 |
spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 |
0.5 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.1 |
0.4 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.2 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.1 |
0.3 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.1 |
0.4 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.1 |
0.1 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.1 |
0.1 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 0.1 |
0.4 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
0.1 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.1 |
0.5 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
0.2 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.1 |
0.1 |
GO:0044793 |
negative regulation by host of viral process(GO:0044793) |
| 0.1 |
0.1 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.1 |
0.2 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.1 |
0.4 |
GO:0097056 |
selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.1 |
0.2 |
GO:1902219 |
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 |
0.1 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.1 |
0.4 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
0.2 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 |
0.5 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.1 |
0.3 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.1 |
0.4 |
GO:0021633 |
optic nerve structural organization(GO:0021633) |
| 0.1 |
1.3 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.1 |
0.1 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.9 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.5 |
GO:0070272 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.1 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.1 |
0.6 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 |
0.1 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 0.1 |
0.1 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.1 |
0.3 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.1 |
0.1 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.1 |
0.6 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.4 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.1 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
1.1 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 |
0.6 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
1.1 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.1 |
0.5 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.1 |
0.1 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
| 0.1 |
0.3 |
GO:0045080 |
positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.1 |
0.6 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
0.1 |
GO:0035166 |
post-embryonic hemopoiesis(GO:0035166) |
| 0.1 |
1.1 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.1 |
0.3 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.1 |
0.1 |
GO:1903564 |
regulation of protein localization to cilium(GO:1903564) positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 |
0.5 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.1 |
0.4 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
1.9 |
GO:0048490 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
0.7 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.1 |
0.3 |
GO:0003097 |
renal water transport(GO:0003097) renal water absorption(GO:0070295) |
| 0.1 |
2.9 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.5 |
GO:0045837 |
negative regulation of membrane potential(GO:0045837) |
| 0.1 |
1.0 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.1 |
0.4 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 |
1.4 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 |
0.3 |
GO:1904666 |
regulation of ubiquitin protein ligase activity(GO:1904666) |
| 0.1 |
1.5 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.1 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.1 |
7.8 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.1 |
0.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.1 |
0.3 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.3 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 0.1 |
0.3 |
GO:0035283 |
rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 |
1.4 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.1 |
0.1 |
GO:0006014 |
D-ribose metabolic process(GO:0006014) |
| 0.1 |
0.1 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.1 |
0.7 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.1 |
5.0 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.1 |
0.5 |
GO:2000860 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.2 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 |
0.2 |
GO:0043311 |
regulation of eosinophil degranulation(GO:0043309) positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 0.1 |
0.7 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.1 |
0.4 |
GO:2000406 |
positive regulation of T cell migration(GO:2000406) |
| 0.1 |
1.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.4 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
0.9 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.1 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.1 |
0.2 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.1 |
0.4 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 0.1 |
0.6 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.1 |
0.1 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.1 |
0.3 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.1 |
0.3 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.2 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.1 |
0.9 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
0.2 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 |
0.1 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.1 |
0.7 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 |
0.2 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.1 |
0.2 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
0.1 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
0.7 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.2 |
GO:1903909 |
regulation of receptor clustering(GO:1903909) |
| 0.1 |
0.4 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.1 |
0.8 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.2 |
GO:0052250 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 |
1.1 |
GO:0042424 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.1 |
1.5 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 |
0.9 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.2 |
GO:0015744 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.1 |
0.1 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.1 |
0.1 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.1 |
1.7 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
0.3 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.1 |
0.1 |
GO:0072535 |
tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) |
| 0.1 |
0.6 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 |
0.2 |
GO:0002778 |
antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.1 |
0.1 |
GO:0032725 |
positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.1 |
0.9 |
GO:0009200 |
deoxyribonucleoside triphosphate metabolic process(GO:0009200) |
| 0.1 |
0.2 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
1.3 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.1 |
1.6 |
GO:1901663 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 |
1.2 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
4.9 |
GO:0010257 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.8 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.3 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.1 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
0.2 |
GO:0097086 |
amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 0.1 |
0.5 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
0.4 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.1 |
0.5 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.3 |
GO:0045964 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 |
0.2 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 |
0.1 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.1 |
GO:0003099 |
positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.1 |
0.2 |
GO:0019605 |
butyrate metabolic process(GO:0019605) |
| 0.1 |
0.2 |
GO:0035498 |
carnosine metabolic process(GO:0035498) |
| 0.1 |
0.2 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.1 |
0.5 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.1 |
1.1 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.1 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 |
0.1 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.1 |
0.1 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.1 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.1 |
0.2 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.1 |
4.9 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.1 |
0.1 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 0.1 |
0.1 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 |
0.4 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.3 |
GO:0042853 |
L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.1 |
0.1 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 |
0.1 |
GO:0097283 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.1 |
0.1 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.1 |
0.1 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 0.1 |
0.1 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
0.2 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.1 |
0.2 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 0.1 |
0.3 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.1 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
1.3 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 |
0.3 |
GO:0001878 |
response to yeast(GO:0001878) |
| 0.1 |
0.1 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.1 |
0.1 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.1 |
0.2 |
GO:0035553 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.2 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.7 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.1 |
0.5 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.1 |
0.2 |
GO:0036302 |
atrioventricular canal development(GO:0036302) |
| 0.1 |
0.1 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 |
0.1 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.1 |
0.5 |
GO:0010908 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.1 |
0.4 |
GO:0014859 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.1 |
0.2 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.1 |
0.3 |
GO:0017014 |
protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
| 0.1 |
0.5 |
GO:2000036 |
regulation of stem cell population maintenance(GO:2000036) |
| 0.1 |
1.6 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.1 |
0.3 |
GO:0014004 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
0.2 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.1 |
0.4 |
GO:0051284 |
positive regulation of sequestering of calcium ion(GO:0051284) |
| 0.1 |
0.2 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.1 |
0.1 |
GO:0097534 |
lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.1 |
0.1 |
GO:0042747 |
circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.1 |
0.3 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.1 |
0.1 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.1 |
0.2 |
GO:0034344 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.1 |
0.7 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 |
0.1 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
0.4 |
GO:0032383 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.1 |
0.2 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
2.3 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 |
0.6 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.1 |
0.3 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.4 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.6 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.4 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
0.1 |
GO:0010897 |
negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.1 |
0.5 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.1 |
0.2 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.1 |
1.2 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.1 |
0.2 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.1 |
1.5 |
GO:0072663 |
protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 |
0.1 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.1 |
0.2 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.1 |
1.4 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.2 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.2 |
GO:0097032 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 |
0.6 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 |
0.1 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.1 |
0.1 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 |
0.3 |
GO:0090116 |
C-5 methylation of cytosine(GO:0090116) |
| 0.1 |
0.9 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.1 |
0.1 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.1 |
1.1 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
0.2 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.1 |
1.7 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.1 |
1.4 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.1 |
0.5 |
GO:0009407 |
toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.0 |
0.0 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.0 |
0.0 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.0 |
0.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.1 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.0 |
0.1 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.0 |
1.3 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.1 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 |
0.2 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.4 |
GO:0051715 |
cytolysis in other organism(GO:0051715) |
| 0.0 |
0.2 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.0 |
0.4 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.0 |
0.6 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
0.1 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.0 |
0.1 |
GO:0071801 |
regulation of podosome assembly(GO:0071801) |
| 0.0 |
0.6 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.0 |
0.1 |
GO:0032906 |
transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.0 |
0.2 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 |
0.1 |
GO:2000439 |
positive regulation of monocyte extravasation(GO:2000439) |
| 0.0 |
0.4 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.0 |
0.3 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 |
0.6 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.0 |
0.0 |
GO:0090134 |
mesendoderm migration(GO:0090133) cell migration involved in mesendoderm migration(GO:0090134) |
| 0.0 |
0.1 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.0 |
0.2 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 |
1.8 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.3 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.3 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.0 |
0.3 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.5 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.0 |
0.7 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
0.0 |
GO:0052200 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) response to host(GO:0075136) |
| 0.0 |
0.9 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.2 |
GO:0061083 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.0 |
0.1 |
GO:0018016 |
N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.0 |
0.8 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.0 |
0.4 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.0 |
2.0 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
| 0.0 |
0.0 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.0 |
0.0 |
GO:0043418 |
homocysteine catabolic process(GO:0043418) |
| 0.0 |
0.1 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.0 |
2.5 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.0 |
0.1 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.0 |
0.4 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.4 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.0 |
0.2 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.0 |
0.8 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.1 |
GO:0002586 |
regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.0 |
0.2 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.0 |
0.4 |
GO:0033129 |
positive regulation of histone phosphorylation(GO:0033129) |
| 0.0 |
0.8 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.0 |
0.2 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.0 |
0.2 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
1.8 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.2 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.0 |
0.2 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.0 |
0.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.0 |
0.3 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.0 |
0.4 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.2 |
GO:0002282 |
microglial cell activation involved in immune response(GO:0002282) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 0.0 |
1.2 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.3 |
GO:1903430 |
negative regulation of cell maturation(GO:1903430) |
| 0.0 |
0.2 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.1 |
GO:0042161 |
plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.0 |
0.1 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 |
0.3 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
0.1 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.0 |
0.3 |
GO:0060433 |
bronchus development(GO:0060433) lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.0 |
0.1 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.0 |
0.2 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.0 |
1.0 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.0 |
0.7 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.0 |
0.5 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.0 |
0.1 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.0 |
0.5 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.0 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.0 |
0.3 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 |
0.9 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.6 |
GO:0009081 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.1 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.0 |
0.0 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.0 |
0.3 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.0 |
0.4 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 |
0.0 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.0 |
0.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.2 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.0 |
0.2 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
2.0 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
5.9 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.6 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.0 |
0.3 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.0 |
0.4 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.0 |
0.4 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.0 |
0.1 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.1 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.0 |
0.2 |
GO:0046778 |
modulation by virus of host gene expression(GO:0039656) modification by virus of host mRNA processing(GO:0046778) |
| 0.0 |
0.2 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.0 |
2.1 |
GO:0033275 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 |
0.2 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.0 |
0.6 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.0 |
0.2 |
GO:0021557 |
oculomotor nerve development(GO:0021557) |
| 0.0 |
0.2 |
GO:0003299 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.2 |
GO:0010310 |
regulation of hydrogen peroxide metabolic process(GO:0010310) |
| 0.0 |
0.4 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.8 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.1 |
GO:1901994 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.0 |
0.1 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.0 |
0.1 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.0 |
0.3 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.2 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.9 |
GO:1900015 |
regulation of cytokine production involved in inflammatory response(GO:1900015) |
| 0.0 |
0.1 |
GO:0043697 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.0 |
0.4 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.0 |
0.5 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.0 |
0.1 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.0 |
0.1 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.0 |
0.1 |
GO:0038156 |
interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.0 |
0.1 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.0 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.1 |
GO:2000329 |
peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.0 |
0.1 |
GO:0009224 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 |
1.1 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.0 |
0.1 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.0 |
0.4 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.0 |
0.1 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.0 |
0.0 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 0.0 |
0.1 |
GO:0098917 |
retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 0.0 |
0.2 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
1.2 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 |
1.1 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.3 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.0 |
0.4 |
GO:0071027 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 |
0.5 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 |
0.6 |
GO:0032648 |
regulation of interferon-beta production(GO:0032648) |
| 0.0 |
0.8 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.1 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.0 |
0.3 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.0 |
0.0 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.0 |
0.0 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.0 |
0.3 |
GO:0044597 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.0 |
0.3 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.0 |
0.1 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.0 |
0.3 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.1 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.0 |
0.2 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.0 |
0.2 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
0.5 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.0 |
0.1 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.0 |
0.2 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 |
0.1 |
GO:0044211 |
CTP salvage(GO:0044211) |
| 0.0 |
0.2 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.3 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.0 |
0.3 |
GO:0006206 |
pyrimidine nucleobase metabolic process(GO:0006206) |
| 0.0 |
0.5 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
0.0 |
GO:2000662 |
interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) |
| 0.0 |
0.0 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.0 |
0.1 |
GO:0008614 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 0.0 |
0.2 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.4 |
GO:0045199 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 |
0.1 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.2 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.0 |
0.1 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 0.0 |
0.5 |
GO:0042559 |
pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.0 |
0.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
3.1 |
GO:0071357 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.0 |
0.2 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 |
0.4 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.0 |
0.2 |
GO:0033668 |
negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.0 |
0.1 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.0 |
1.3 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.0 |
0.1 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.0 |
0.3 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.1 |
GO:0046247 |
tetraterpenoid metabolic process(GO:0016108) carotenoid metabolic process(GO:0016116) carotene catabolic process(GO:0016121) xanthophyll metabolic process(GO:0016122) terpene catabolic process(GO:0046247) |
| 0.0 |
0.6 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
| 0.0 |
0.2 |
GO:0003160 |
endocardium morphogenesis(GO:0003160) |
| 0.0 |
0.1 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.0 |
3.0 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.1 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.0 |
0.2 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 0.0 |
0.1 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.0 |
0.4 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.0 |
0.1 |
GO:1905216 |
positive regulation of RNA binding(GO:1905216) |
| 0.0 |
0.0 |
GO:0009080 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.0 |
0.1 |
GO:0032048 |
cardiolipin metabolic process(GO:0032048) |
| 0.0 |
0.1 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.0 |
0.0 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.0 |
1.4 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.2 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.0 |
0.1 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.0 |
0.0 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 0.0 |
0.2 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.2 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.0 |
0.0 |
GO:0010536 |
positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.0 |
0.2 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.0 |
0.1 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.0 |
0.1 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.0 |
0.2 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 |
0.3 |
GO:0045187 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.0 |
0.4 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.3 |
GO:0003266 |
regulation of secondary heart field cardioblast proliferation(GO:0003266) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.0 |
0.1 |
GO:1904744 |
positive regulation of telomeric DNA binding(GO:1904744) |
| 0.0 |
0.1 |
GO:0009804 |
coumarin metabolic process(GO:0009804) |
| 0.0 |
0.4 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.0 |
0.1 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.0 |
1.5 |
GO:1901016 |
regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.0 |
0.5 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.0 |
0.1 |
GO:1901318 |
negative regulation of sperm motility(GO:1901318) |
| 0.0 |
0.5 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.1 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.0 |
0.1 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.0 |
0.5 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.0 |
0.7 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.0 |
0.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.0 |
0.6 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 |
0.0 |
GO:1903671 |
negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.0 |
0.5 |
GO:0071871 |
response to epinephrine(GO:0071871) |
| 0.0 |
0.1 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.0 |
0.1 |
GO:0014744 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of muscle adaptation(GO:0014744) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.0 |
0.1 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.4 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.0 |
0.1 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.0 |
0.3 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 |
0.2 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 |
0.5 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.1 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.0 |
0.2 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.1 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.0 |
0.1 |
GO:1903259 |
exon-exon junction complex disassembly(GO:1903259) |
| 0.0 |
1.1 |
GO:0061245 |
establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
| 0.0 |
0.2 |
GO:0010578 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.1 |
GO:0030812 |
negative regulation of nucleotide catabolic process(GO:0030812) |
| 0.0 |
0.4 |
GO:0048665 |
neuron fate specification(GO:0048665) |
| 0.0 |
0.2 |
GO:0060039 |
pericardium development(GO:0060039) |
| 0.0 |
0.1 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 |
0.5 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.0 |
0.2 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.0 |
0.3 |
GO:0048679 |
regulation of axon regeneration(GO:0048679) |
| 0.0 |
0.1 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.0 |
2.6 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 |
0.1 |
GO:2000403 |
positive regulation of lymphocyte migration(GO:2000403) |
| 0.0 |
0.9 |
GO:1903363 |
negative regulation of cellular protein catabolic process(GO:1903363) |
| 0.0 |
0.3 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.0 |
0.1 |
GO:0060632 |
regulation of microtubule-based movement(GO:0060632) |
| 0.0 |
0.2 |
GO:1903432 |
regulation of TORC1 signaling(GO:1903432) |
| 0.0 |
0.1 |
GO:1990654 |
regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
| 0.0 |
0.3 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.0 |
0.0 |
GO:0032645 |
granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) |
| 0.0 |
1.0 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.6 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.1 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 0.0 |
0.6 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.0 |
0.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.1 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.0 |
0.3 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.2 |
GO:1902572 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.1 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.0 |
0.1 |
GO:2000681 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.0 |
0.3 |
GO:0015669 |
gas transport(GO:0015669) oxygen transport(GO:0015671) |
| 0.0 |
0.3 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.0 |
0.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.1 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.0 |
0.0 |
GO:0032071 |
regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.0 |
0.2 |
GO:0019375 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 |
0.3 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.0 |
0.2 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.4 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 |
0.9 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.0 |
0.5 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.0 |
0.3 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 |
0.0 |
GO:1903626 |
positive regulation of DNA catabolic process(GO:1903626) |
| 0.0 |
0.1 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.0 |
0.4 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.1 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.0 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.0 |
0.2 |
GO:1901314 |
negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.0 |
0.0 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 |
1.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.1 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.0 |
1.6 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.0 |
0.2 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.0 |
0.2 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.0 |
0.5 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 |
0.0 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.0 |
0.0 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.0 |
0.3 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.0 |
0.1 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 |
0.2 |
GO:0097647 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.0 |
0.0 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.0 |
0.1 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.0 |
0.9 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 |
0.5 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.0 |
0.1 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 0.0 |
0.4 |
GO:2000772 |
regulation of cellular senescence(GO:2000772) |
| 0.0 |
0.0 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.0 |
0.4 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 |
0.1 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 |
0.2 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.0 |
GO:0036245 |
cellular response to menadione(GO:0036245) |
| 0.0 |
0.0 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.0 |
0.1 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.0 |
0.0 |
GO:0006565 |
L-serine catabolic process(GO:0006565) |
| 0.0 |
0.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.0 |
GO:1902714 |
negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.0 |
0.6 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.0 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 |
0.2 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 |
0.4 |
GO:1904776 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.0 |
0.2 |
GO:0071674 |
mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.0 |
0.1 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.0 |
0.1 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.0 |
0.1 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.0 |
0.1 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.0 |
0.1 |
GO:0060681 |
branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.0 |
0.1 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.0 |
0.1 |
GO:0010607 |
negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
| 0.0 |
0.0 |
GO:0032470 |
positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
| 0.0 |
0.1 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.0 |
0.0 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.0 |
0.3 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.3 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.0 |
0.1 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.0 |
0.1 |
GO:1990519 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.0 |
0.1 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.0 |
0.1 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.0 |
0.1 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.0 |
0.6 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.5 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.0 |
0.1 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 |
0.0 |
GO:0035864 |
response to potassium ion(GO:0035864) |
| 0.0 |
0.1 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.0 |
0.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.1 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:0097210 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.3 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.4 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.3 |
GO:0065002 |
intracellular protein transmembrane transport(GO:0065002) |
| 0.0 |
0.1 |
GO:0003402 |
planar cell polarity pathway involved in axis elongation(GO:0003402) |
| 0.0 |
0.3 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.0 |
0.6 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.0 |
0.3 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.0 |
0.2 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.1 |
GO:0048243 |
norepinephrine secretion(GO:0048243) |
| 0.0 |
0.1 |
GO:0098700 |
neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.0 |
0.2 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.0 |
GO:0044546 |
NLRP3 inflammasome complex assembly(GO:0044546) |
| 0.0 |
0.4 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.0 |
0.1 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.1 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 |
0.1 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.0 |
0.0 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.0 |
0.0 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.0 |
0.1 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.1 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.0 |
GO:0045919 |
positive regulation of cytolysis(GO:0045919) |
| 0.0 |
0.1 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 |
0.2 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.0 |
0.6 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.0 |
0.0 |
GO:0036005 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.0 |
0.1 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.2 |
GO:0032986 |
protein-DNA complex disassembly(GO:0032986) |
| 0.0 |
0.1 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) |
| 0.0 |
0.1 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.0 |
0.0 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.0 |
GO:1901073 |
N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.0 |
0.2 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 |
0.1 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.0 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.0 |
0.1 |
GO:0009070 |
serine family amino acid biosynthetic process(GO:0009070) |
| 0.0 |
0.2 |
GO:0001825 |
blastocyst formation(GO:0001825) |
| 0.0 |
0.1 |
GO:2000322 |
regulation of glucocorticoid receptor signaling pathway(GO:2000322) |
| 0.0 |
0.1 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.0 |
1.9 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.1 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.0 |
0.2 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.0 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.0 |
0.0 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.0 |
0.4 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.6 |
GO:0070830 |
bicellular tight junction assembly(GO:0070830) |
| 0.0 |
0.2 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.0 |
0.2 |
GO:0006418 |
tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 |
0.1 |
GO:0002396 |
MHC protein complex assembly(GO:0002396) |
| 0.0 |
0.1 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.0 |
0.1 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.0 |
0.0 |
GO:1901162 |
primary amino compound biosynthetic process(GO:1901162) |
| 0.0 |
0.1 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.0 |
0.3 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.0 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 0.0 |
0.0 |
GO:0090085 |
regulation of protein deubiquitination(GO:0090085) |
| 0.0 |
0.2 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 |
0.0 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 0.0 |
0.0 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.0 |
0.0 |
GO:0090154 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 |
0.1 |
GO:1901072 |
glucosamine-containing compound catabolic process(GO:1901072) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.1 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.0 |
0.0 |
GO:0051797 |
regulation of hair follicle development(GO:0051797) |
| 0.0 |
0.0 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
| 0.0 |
0.1 |
GO:0046102 |
inosine metabolic process(GO:0046102) |
| 0.0 |
0.1 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 0.0 |
0.1 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.0 |
0.1 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.0 |
0.0 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.1 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.0 |
0.0 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.0 |
0.0 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.0 |
0.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.6 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.0 |
0.4 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.0 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.0 |
0.0 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.1 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.0 |
0.3 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) |
| 0.0 |
0.1 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.0 |
0.0 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
